News  |  Events  |  Media Coverage  |  Alumni Features  |  Trending @ RBS

The global president of Bayer Healthcare Pharmaceuticals said innovation will continue to be a key driver for the biopharmaceutical industry as the U.S. population ages, healthcare budgets shrink and pressure mounts to produce new and affordable treatments.

In a keynote speech at Rutgers Business School's annual healthcare symposium, Dieter Weinand highlighted some of the industry's biggest challenges, including the increasing complexity of drug development and the continued need for reflecting innovation in drug pricing.

"Weinand said outcomes-based data may begin to better guide the industry's use of differential pricing of prescription drugs. But differential pricing, he said, "cannot come at the cost of innovation."

The annual healthcare symposium is one of Rutgers Business School's signature thought leadership events, providing a showcase for the pharmaceutical management program as well as the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues. The event offers students, faculty, alumni and industry professionals a unique opportunity to hear high-level executives speak candidly about issues impacting the biopharmaceutical business.

Professor Mahmud Hassan, who is also director of the Lerner Center, opened the symposium by noting that it allows for the "exchange of ideas" that is at the heart of the center's purpose. Hassan also noted that Rutgers Business School was recently listed among the Top 5 schools in the world for MBA students who want to focus on pharmaceutical management.

Weinand's talk set the stage for a morning-long discussion, which included remarks from a number of leading industry executives and questions from the audience. In addition to pricing, the speakers exchanged views on the unsustainability of the current U.S. healthcare system as well as the industry's current focus on developing specialty drugs.

Read full story

New We R Business video highlights the student experience

"Our mission really is to give students a great academic experience and help them to develop and be successful," Robert Kurland, associate dean for undergraduate programs in Newark, says in the video.

Kurland and other deans, faculty and staff helped to make this segment of the We R Business video series.

From teaching business concepts and mentoring to professional enrichment, listen to everything that is part of the student experience at Rutgers Business School.


Watch the video

Rutgers ranks No. 9 for return on investment, according to Fortune.com.
MBA students win inaugural BNY Mellon Social Finance Prize

Rutgers, The State University of New Jersey — founded 1766
© 2014 Rutgers Business School — Newark & New Brunswick